EMA Accepts Mylan’s Filing for Biosimilar of Sanofi’s Lantus Insulin Analog
By
Mylan and Biocon, a biopharmaceutical company headquarterd in Bangalore, India, report that the European Medicines Agency has accepted for review Mylan’s marketing authorization application for insulin glargine, a long-acting insulin…